MGI Tech Launches VisiOmics in Europe and Unveils AI-Enabled Pathology Portfolio at ECP 2026
From Tissue to Answer: Integrated Solutions for Tissue and Molecular Pathology, from multiplex immunofluorescence to sample-to-result sequencing, powered by AISTOCKHOLM, Sept. 15, 2026 // -- MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.